- Report
- August 2025
- 181 Pages
Global
From €3164EUR$3,545USD£2,719GBP
€3515EUR$3,939USD£3,021GBP
- Report
- July 2025
- 82 Pages
United States
From €3124EUR$3,500USD£2,684GBP
- Report
- March 2024
- 200 Pages
Global
From €3704EUR$4,150USD£3,183GBP
- Report
- March 2024
- 200 Pages
Global
From €3704EUR$4,150USD£3,183GBP
- Report
- June 2023
- 33 Pages
Global
From €1740EUR$1,950USD£1,496GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4418EUR$4,950USD£3,797GBP
- Report
- June 2025
- 400 Pages
Global
From €4417EUR$4,949USD£3,796GBP
- Report
- April 2023
- 160 Pages
Global
From €4417EUR$4,949USD£3,796GBP
- Report
- April 2023
- 116 Pages
Global
From €4016EUR$4,500USD£3,451GBP
- Report
- February 2023
- 117 Pages
Global
From €4016EUR$4,500USD£3,451GBP
- Report
- April 2023
- 110 Pages
Global
From €4239EUR$4,750USD£3,643GBP
- Report
- July 2025
- 350 Pages
Global
From €4417EUR$4,949USD£3,796GBP
- Report
- July 2025
- 350 Pages
Global
From €4417EUR$4,949USD£3,796GBP
- Report
- April 2023
- 140 Pages
Global
From €4417EUR$4,949USD£3,796GBP
- Report
- March 2023
- 140 Pages
Global
From €4417EUR$4,949USD£3,796GBP
- Report
- June 2025
- 144 Pages
Global
From €3525EUR$3,950USD£3,030GBP
- Report
- April 2024
- 124 Pages
Global
From €3525EUR$3,950USD£3,030GBP
- Report
- March 2026
- 381 Pages
China
From €4328EUR$4,850USD£3,720GBP
- Report
- March 2026
- 170 Pages
Germany
From €4328EUR$4,850USD£3,720GBP
- Report
- March 2026
- 342 Pages
Canada
From €4328EUR$4,850USD£3,720GBP

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more